arteriosclerotic cardiovascular disease
Conditions
Interventions
control group:placebo
Sponsors
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Eligibility
Sex/Gender
All
Age
20 Years to 85 Years
Inclusion criteria
Inclusion criteria: 1) Aged 20 to 85 years, voluntarily participate in the study and sign the informed consent; 2) patients with coronary lesion stenosis >= 20% but 0.80, without vascular reconstruction.
Exclusion criteria
Exclusion criteria: 1) Pregnant and nursing women; 2) ALT or AST >=2 ULN; 3) severe renal insufficiency (Cr > 177umol/L); 4) hemoglobin < 90g/L or platelet < 100x10^9/L or leukocyte < 3.0x10^9/L; 5) acute myocardial infarction, stroke, acute coronary syndrome, and coronary artery PCI in the last 3 months; 6) Participated in other clinical trials within the past 1 month; 7) Screening subjects with a history of malignant tumor in the previous 5 years; 8) Mental diseases; 9) Life expectancy is shorter than the duration of the experiment; 10) Not suitable for participants.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Minimum lumen area of the coronary artery; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood fractional flow eserve; | — |
Countries
China
Contacts
Public ContactJia Zhou
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM
Outcome results
None listed